Net profit of Nectar Lifescience reported to Rs 1.57 crore in the quarter ended December 2023 as against net loss of Rs 9.29 crore during the previous quarter ended December 2022. Sales rose 31.40% to Rs 452.16 crore in the quarter ended December 2023 as against Rs 344.12 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales452.16344.12 31 OPM %9.330.42 - PBDT17.83-2.78 LP PBT2.46-17.56 LP NP1.57-9.29 LP Powered by Capital Market - Live News

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net profit of Nectar Lifescience reported to Rs 1.02 crore in the quarter ended September 2023 as against net loss of Rs 22.47 crore during the previous quarter ended September 2022. Sales rose 2.40% to Rs 397.96 crore in the quarter ended September 2023 as against Rs 388.64 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales397.96388.64 2 OPM %6.75-1.90 - PBDT16.95-17.68 LP PBT1.64-32.47 LP NP1.02-22.47 LP Powered by Capital Market - Live News

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 10 November 2023.Powered by Capital Market - Live News

Net profit of Nectar Lifescience declined 53.33% to Rs 1.82 crore in the quarter ended June 2023 as against Rs 3.90 crore during the previous quarter ended June 2022. Sales declined 2.21% to Rs 394.12 crore in the quarter ended June 2023 as against Rs 403.02 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales394.12403.02 -2 OPM %9.0210.37 - PBDT18.3920.81 -12 PBT3.066.11 -50 NP1.823.90 -53 Powered by Capital Market - Live News